

Clinical trial participant receives first dose of UMass Chan-developed treatment for alopecia areata by Alys Pharmaceuticals
A siRNA therapeutic for dermatological diseases developed at UMass Chan Medical School has entered the clinical trial phase.
Category: Graduate School of Biomedical Sciences,School of Medicine,Dermatology,Faculty,Research,Anastasia Khvorova,SiRNA,John Harris,RNA Therapeutics Institute,Genetics,Latest News,Khvorova Lab,BRIDGE,Top Stories,Julia Alterman
Read more